PeptiDream Correlations
| PPTDFDelisted Stock | USD 17.00 0.00 0.00% |
The current 90-days correlation between PeptiDream and Innovent Biologics is 0.02 (i.e., Significant diversification). The correlation of PeptiDream is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
PeptiDream Correlation With Market
Good diversification
The correlation between PeptiDream and DJI is -0.1 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding PeptiDream and DJI in the same portfolio, assuming nothing else is changed.
PeptiDream |
The ability to find closely correlated positions to PeptiDream could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace PeptiDream when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back PeptiDream - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling PeptiDream to buy it.
Moving together with PeptiDream Pink Sheet
| 0.8 | BMA | Banco Macro SA | PairCorr |
| 0.78 | PLTR | Palantir Technologies Aggressive Push | PairCorr |
| 0.67 | DIS | Walt Disney Sell-off Trend | PairCorr |
| 0.72 | CVX | Chevron Corp Sell-off Trend | PairCorr |
| 0.69 | TRV | The Travelers Companies Fiscal Year End 17th of January 2025 | PairCorr |
| 0.68 | AA | Alcoa Corp Fiscal Year End 15th of January 2025 | PairCorr |
| 0.7 | T | ATT Inc Fiscal Year End 22nd of January 2025 | PairCorr |
| 0.77 | JPM | JPMorgan Chase Sell-off Trend | PairCorr |
| 0.79 | BAC | Bank of America Aggressive Push | PairCorr |
Moving against PeptiDream Pink Sheet
| 0.9 | AULT | Ault Alliance Symbol Change | PairCorr |
| 0.85 | REGN | Regeneron Pharmaceuticals | PairCorr |
| 0.84 | CSLLY | CSL | PairCorr |
| 0.77 | NVO | Novo Nordisk AS | PairCorr |
| 0.76 | NONOF | Novo Nordisk AS | PairCorr |
| 0.75 | CMXHF | CSL Limited | PairCorr |
| 0.7 | VLCN | Volcon Inc | PairCorr |
| 0.65 | AKO-B | Embotelladora Andina | PairCorr |
| 0.62 | QSAM | Qsam Biosciences | PairCorr |
| 0.51 | WF | Woori Financial Group | PairCorr |
| 0.86 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.76 | PFE | Pfizer Inc Aggressive Push | PairCorr |
| 0.6 | MMM | 3M Company Fiscal Year End 28th of January 2025 | PairCorr |
| 0.55 | BA | Boeing Fiscal Year End 29th of January 2025 | PairCorr |
| 0.44 | VZ | Verizon Communications Sell-off Trend | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between PeptiDream Pink Sheet performing well and PeptiDream Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze PeptiDream's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| IVBXF | 1.81 | 0.02 | 0.00 | 0.11 | 0.00 | 5.48 | 24.34 | |||
| TLPPF | 2.88 | 0.28 | 0.05 | 0.76 | 3.70 | 5.78 | 17.91 | |||
| KROS | 2.10 | 0.23 | 0.11 | 0.30 | 2.20 | 4.39 | 16.94 | |||
| MAIA | 3.91 | (0.29) | 0.00 | (0.23) | 0.00 | 8.37 | 28.10 | |||
| GRPH | 2.36 | (0.07) | 0.00 | 0.49 | 0.00 | 4.79 | 14.40 | |||
| BZYR | 7.61 | 0.90 | 0.04 | 0.39 | 9.51 | 24.24 | 119.30 | |||
| PROK | 4.58 | (0.46) | (0.01) | 0.01 | 6.25 | 8.97 | 33.89 | |||
| OBIO | 3.78 | (0.38) | 0.00 | (0.05) | 0.00 | 7.24 | 25.42 | |||
| LIXT | 4.74 | 0.85 | 0.12 | (2.27) | 5.35 | 7.95 | 70.38 | |||
| ONPH | 6.01 | 1.04 | 0.00 | (0.43) | 0.00 | 0.00 | 196.67 |
View PeptiDream Related Equities
| Risk & Return | Correlation |
PeptiDream Corporate Management
| Yuko Okimoto | Ex Department | Profile | |
| Keiichi Masuya | Ex COO | Profile | |
| Kiyofumi Kaneshiro | Ex CFO | Profile | |
| Toshiyuki Iwata | Head Relations | Profile |
Still Interested in PeptiDream?
Investing in delisted pink sheets can be risky, as the pink sheet is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.